Pfizer-BioNTech Seeks Emergency Use of Covid Booster for Children Aged 5-11 Pfizer-BioNTech seeks an FDA emergency use approval in the US for children aged 5-11. This booster dose is intended for the original Covid strain, Omicron, and BA.4 and BA.5 subvariants. by Joaquin Victor Tacla
Health CDC, Fauci Thinks COVID-19 Boosters Are Not Essential As of The Moment, to Address its Need in Briefing by Isaiah Richard
Health Pfizer COVID-19 Booster to Get FDA Approval in August, Third Shot to Significantly Improve Immunity by Isaiah Richard
Health mRNAs Are The Future of Vaccines After Pfizer, Moderna's Success Against COVID—HIV, Cancers Next-in-Line by Isaiah Richard
Health FDA Approves Pfizer's COVID-19 Vaccine Emergency Use Despite Fears From Severe Allergic Reactions Reported in UK by Isaiah Alonzo